Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 6 | 2022 | 150 | 2.570 |
Why?
|
| Fetal Growth Retardation | 4 | 2023 | 56 | 2.240 |
Why?
|
| Obstetric Labor, Premature | 4 | 2022 | 76 | 2.140 |
Why?
|
| Fetal Membranes, Premature Rupture | 4 | 2020 | 45 | 1.910 |
Why?
|
| Pregnancy | 20 | 2023 | 2334 | 1.870 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2020 | 79 | 1.640 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 81 | 1.600 |
Why?
|
| Umbilical Arteries | 2 | 2020 | 9 | 1.340 |
Why?
|
| Erythromycin | 2 | 2018 | 13 | 1.230 |
Why?
|
| Azithromycin | 2 | 2018 | 13 | 1.220 |
Why?
|
| Fetal Heart | 2 | 2019 | 41 | 1.200 |
Why?
|
| Fetofetal Transfusion | 2 | 2017 | 3 | 1.160 |
Why?
|
| Fetoscopy | 2 | 2017 | 4 | 1.160 |
Why?
|
| Infant, Newborn | 11 | 2023 | 2455 | 1.150 |
Why?
|
| Stillbirth | 2 | 2023 | 12 | 1.080 |
Why?
|
| Hypoglycemia | 2 | 2022 | 72 | 0.980 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2022 | 91 | 0.970 |
Why?
|
| Retrospective Studies | 15 | 2023 | 7277 | 0.910 |
Why?
|
| Birth Weight | 2 | 2023 | 186 | 0.880 |
Why?
|
| Fetal Diseases | 1 | 2022 | 64 | 0.810 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2022 | 46 | 0.800 |
Why?
|
| Twins, Dizygotic | 1 | 2021 | 25 | 0.760 |
Why?
|
| Growth Charts | 1 | 2021 | 16 | 0.760 |
Why?
|
| Labor, Induced | 2 | 2022 | 18 | 0.740 |
Why?
|
| Fetal Weight | 1 | 2020 | 33 | 0.730 |
Why?
|
| Cesarean Section | 2 | 2022 | 101 | 0.710 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 73 | 0.700 |
Why?
|
| Pregnancy in Diabetics | 2 | 2022 | 70 | 0.680 |
Why?
|
| Thromboxane B2 | 1 | 2019 | 108 | 0.650 |
Why?
|
| Drug Resistance | 1 | 2019 | 223 | 0.620 |
Why?
|
| Laser Coagulation | 1 | 2017 | 8 | 0.610 |
Why?
|
| Female | 20 | 2023 | 38074 | 0.600 |
Why?
|
| Aspirin | 1 | 2019 | 295 | 0.590 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 694 | 0.580 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 202 | 0.560 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 373 | 0.550 |
Why?
|
| Endometrial Ablation Techniques | 1 | 2016 | 1 | 0.550 |
Why?
|
| Uterine Rupture | 1 | 2016 | 4 | 0.550 |
Why?
|
| Abortion, Therapeutic | 1 | 2016 | 5 | 0.540 |
Why?
|
| Twins | 1 | 2016 | 42 | 0.540 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2022 | 186 | 0.540 |
Why?
|
| Laser Therapy | 1 | 2016 | 54 | 0.540 |
Why?
|
| Echocardiography | 1 | 2019 | 515 | 0.530 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 362 | 0.510 |
Why?
|
| Pregnancy Outcome | 4 | 2022 | 157 | 0.510 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 596 | 0.460 |
Why?
|
| Humans | 20 | 2023 | 68618 | 0.430 |
Why?
|
| Gestational Age | 4 | 2023 | 389 | 0.420 |
Why?
|
| Cost-Benefit Analysis | 3 | 2019 | 504 | 0.400 |
Why?
|
| Heart Ventricles | 1 | 2016 | 738 | 0.390 |
Why?
|
| Adult | 10 | 2022 | 21403 | 0.380 |
Why?
|
| Cervix Uteri | 2 | 2021 | 64 | 0.370 |
Why?
|
| Ultrasonography, Doppler | 2 | 2020 | 57 | 0.330 |
Why?
|
| Young Adult | 5 | 2020 | 5717 | 0.290 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 1753 | 0.260 |
Why?
|
| Logistic Models | 2 | 2021 | 1420 | 0.250 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1046 | 0.250 |
Why?
|
| Vital Statistics | 1 | 2022 | 2 | 0.210 |
Why?
|
| Fetal Development | 1 | 2023 | 70 | 0.210 |
Why?
|
| Betamethasone | 1 | 2022 | 24 | 0.200 |
Why?
|
| Steroids | 1 | 2022 | 84 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 1026 | 0.190 |
Why?
|
| Labor Stage, First | 1 | 2020 | 5 | 0.190 |
Why?
|
| Glucose | 1 | 2022 | 307 | 0.180 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 46 | 0.180 |
Why?
|
| Diastole | 1 | 2020 | 161 | 0.170 |
Why?
|
| Reference Values | 1 | 2021 | 579 | 0.170 |
Why?
|
| Ohio | 1 | 2019 | 64 | 0.170 |
Why?
|
| Maternal Age | 1 | 2019 | 70 | 0.170 |
Why?
|
| Linear Models | 1 | 2021 | 521 | 0.170 |
Why?
|
| Pregnancy, High-Risk | 1 | 2019 | 14 | 0.170 |
Why?
|
| Glyburide | 1 | 2018 | 19 | 0.160 |
Why?
|
| Metformin | 1 | 2018 | 63 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 62 | 0.150 |
Why?
|
| Pregnancy, Twin | 1 | 2017 | 9 | 0.150 |
Why?
|
| Fetal Death | 1 | 2017 | 49 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2018 | 411 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2022 | 2358 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2016 | 50 | 0.140 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 58 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2019 | 7029 | 0.130 |
Why?
|
| Health Status Indicators | 1 | 2016 | 117 | 0.130 |
Why?
|
| Insulin | 1 | 2018 | 619 | 0.130 |
Why?
|
| Mass Screening | 1 | 2019 | 843 | 0.110 |
Why?
|
| Myocardium | 1 | 2016 | 1204 | 0.090 |
Why?
|
| Autopsy | 1 | 2022 | 56 | 0.050 |
Why?
|
| Fetus | 1 | 2022 | 157 | 0.050 |
Why?
|
| Cervical Length Measurement | 1 | 2020 | 2 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2020 | 737 | 0.040 |
Why?
|
| Male | 1 | 2018 | 37321 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1603 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1076 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2007 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 5731 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7367 | 0.020 |
Why?
|